Nanopore Sequencing & Informatic challenges
Oxford Nanopore Technologies aim to enable the analysis of any living thing, by any person, in any environment. The world's first and only nanopore DNA sequencer, the MinION is a portable, real time, long-read, low cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or even microgravity biology.
Gordon will talk the about the technology, applications and future direction. Stuart will talk about the nanopore signal, computational methods and informatics challenges associated with reading DNA directly.
About the speakers:
Gordon Sanghera was co-founder of Oxford Nanopore, together with Hagan Bayley and IP Group. He was appointed CEO in June 2005. He brings over 20 years' experience in the design, development and global launch of disruptive platform sensor technologies. Dr Sanghera's PhD in bioelectronics sensing was followed by a career at MediSense an Oxford spin-out that delivered a new generation glucose technology to the market. Following the acquisition of MediSense by Abbott Laboratories Dr Sanghera held both UK and US VP and Director-level positions, including VP World Wide Marketing, Research Director and Manufacturing Process Development Director. Before its acquisition by Abbott, Gordon led the R&D of Medisense Inc. where he was instrumental in the launch of several generations of blood glucose bio-electronic systems for the consumer and hospital medical markets. He has also developed and validated production processes to meet with the regulatory requirements for USA and Europe. Gordon has a PhD in bio-electronic technology and a degree in Chemistry.
Stuart Reid is Senior Director of Development at Oxford Nanopore. Stuart is responsible for delivery of the company's nanopore-based sensing platforms and applications into the marketplace. He joined Oxford Nanopore in 2006, with a particular interest in biophysical systems and signals analysis, following a DPhil in Physics (Bionanotechnology) from Oxford University as part of the Life Sciences Interface Doctoral Training Centre. He has been instrumental at all stages of the product development cycle, from the fundamental science and invention, though specification, implementation and optimisation to delivery into the marketplace.
Further Reading at Link https://nanoporetech.com/